{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:42:57Z","timestamp":1777545777892,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1023\/a:1018951025493","type":"journal-article","created":{"date-parts":[[2003,2,19]],"date-time":"2003-02-19T17:07:13Z","timestamp":1045674433000},"page":"1399-1406","source":"Crossref","is-referenced-by-count":17,"title":["Synthesis and Preclinical Pharmacology of 2-(2-Aminopyrimidinio) Ethylidene-1,1-Bisphosphonic Acid Betaine (ISA-13-1)-A Novel Bisphosphonate"],"prefix":"10.1007","volume":"16","author":[{"given":"Hagit","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan S.","family":"Alferiev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"M\u00f6nkk\u00f6nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus J.","family":"Seibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taly","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviva","family":"Ezra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vered","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Stepensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilah","family":"Sagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asher","family":"Ornoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natan","family":"Patlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"H\u00e4gele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amnon","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gershon","family":"Golomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"303677_CR1","volume-title":"Bisphosphonates in bone disease: From the laboratory to the patient","author":"H. Fleisch","year":"1997","unstructured":"H. Fleisch. Bisphosphonates in bone disease: From the laboratory to the patient, The Parthenon Publishing Group, NY, 1997."},{"key":"303677_CR2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0022-3565(25)12897-8","volume":"277","author":"N. Makkonen","year":"1996","unstructured":"N. Makkonen, M. R. Hirvonen, T. Teravainen, K. Savolainen, and J. Monkkonen. Different effects of three bisphosphonates on nitric oxide production by RAW 264 macrophage-like cells in vitro. J. Pharmacol. Exp. Ther.\n277:1097-1102 (1996).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"303677_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pharmtox.38.1.375","volume":"38","author":"G. A. Rodan","year":"1998","unstructured":"G. A. Rodan. Mechanisms of action of bisphosphonates. Annu. Rev. Pharmacol. Toxicol.\n38:375-388 (1998).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"303677_CR4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","volume":"18","author":"J. H. Lin","year":"1996","unstructured":"J. H. Lin. Bisphosphonates: A review of their pharmacokinetic properties. Bone\n18:75-85 (1996).","journal-title":"Bone"},{"key":"303677_CR5","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199610033351403","volume":"335","author":"P. C. D. Groen","year":"1996","unstructured":"P. C. D. Groen, et al. Esophagitis associated with the use of alendronate. New Engl. J. Med.\n335:1016-1021 (1996).","journal-title":"New Engl. J. Med."},{"key":"303677_CR6","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/jps.2600831218","volume":"83","author":"J. H. Lin","year":"1994","unstructured":"J. H. Lin, I.-W. Chen, and F. A. Deluna. On the absorption of alendronate in rats. J. Pharm. Sci.\n83:1741-1746 (1994).","journal-title":"J. Pharm. Sci."},{"key":"303677_CR7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jps.2600830521","volume":"83","author":"I. M. Twiss","year":"1994","unstructured":"I. M. Twiss, R. de Water, J. den Hartigh, R. Sparidans, W. Ramp-Koopmanschap, H. Brill, M. Wijdeveld, and P. Vermeij. Cytotoxic effects of Pamidronate on monolayers of human intestinal epithelial (Caco-2) cells and its epithelial transport. J. Pharm. Sci.\n83:699-703 (1994).","journal-title":"J. Pharm. Sci."},{"key":"303677_CR8","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/13543784.3.12.1255","volume":"3","author":"W. K. Sietsema","year":"1994","unstructured":"W. K. Sietsema and F. H. Ebetino. Bisphophonates in development for metabolic bone disease. Exp. Opin. Invest. Drugs\n3:1255-1276 (1994).","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"303677_CR9","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/jbmr.5650091206","volume":"9","author":"E. Van Beek","year":"1994","unstructured":"E. Van Beek, M. Hoekstra, M. Van de Ruit, C. W. G. M. Lowik, and S. E. Papapoulos. Structural requirements for bisphosphonate actions in vitro. J. Bone Miner. Res.\n9:1875-1882 (1994).","journal-title":"J. Bone Miner. Res."},{"key":"303677_CR10","first-page":"181","volume-title":"Animal models for human related calcium metabolic disorders","author":"J. M. Van Gelder","year":"1995","unstructured":"J. M. Van Gelder and G. Golomb. The evaluation of bisphosphonates as potential drugs for the treatment of calcium-related disorders. In A. Ornoy (eds.), Animal models for human related calcium metabolic disorders, CRC Press, Boca Raton, 1995, pp. 181-205."},{"key":"303677_CR11","first-page":"234254x","volume":"117","author":"N. V. Mikhalin","year":"1992","unstructured":"N. V. Mikhalin, I. S. Alferiev, I. L. Kotlyarevskii, and A. V. Krasnukhina. Method of preparation of higher 1-hydroxyalkylidene-1,1-diphosphonic acids or their mixtures or salts. Russian Patent SU 1,719,405. Chem. Abst.\n117:234254x (1992).","journal-title":"Chem. Abst."},{"issue":"8","key":"303677_CR12","first-page":"1528","volume":"44","author":"I. S. Alferiev","year":"1995","unstructured":"I. S. Alferiev and N. V. Mikhalin. Reactions of vinylidenediphosphonic acid with nucleophiles, Commun. 5, Addition of heterocyclic amines and trimethylamine to vinylidenediphosphonic acid. Bull. Russ. Acad. Sci., Div. Chem. Sci.\n44(8):1528-1530 (1995).","journal-title":"Bull. Russ. Acad. Sci., Div. Chem. Sci."},{"key":"303677_CR13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0378-4347(95)00531-5","volume":"678","author":"L. E. King","year":"1996","unstructured":"L. E. King and R. Vieth. Extraction and measurement of pamidronate from bone samples using automated pre-column derivatization, high-performance liquid chromatography and fluoresence detection. J. Chromatogr.\n678:325-330 (1996).","journal-title":"J. Chromatogr."},{"issue":"4","key":"303677_CR14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1023\/A:1011990129437","volume":"15","author":"H. Cohen","year":"1998","unstructured":"H. Cohen, V. Solomon, I. S. Alferiev, E. Breuer, A. Ornoy, N. Patlas, N. Eidelman, G. Hagele, and G. Golomb. Bisphosphonates and tetracycline: Experimental models for their evaluation in calcium-related disorders. Pharm. Res.\n15(4):606-613 (1998).","journal-title":"Pharm. Res."},{"key":"303677_CR15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1018967727156","volume":"11","author":"P. W. Swaan","year":"1994","unstructured":"P. W. Swaan, G. J. Marks, F. M. Ryan, and P. L. Smith. Determination of transport rates for arginine and acetaminophen in rabbit intestinal tissues in vitro. Pharm. Res.\n11:283-287 (1994).","journal-title":"Pharm. Res."},{"issue":"10","key":"303677_CR16","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/clinchem\/42.10.1621","volume":"42","author":"S. P. Robins","year":"1996","unstructured":"S. P. Robins, A. Duncan, N. Wilson, and B. J. Evans. Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation. Clin. Chem.\n42(10):1621-1626 (1996).","journal-title":"Clin. Chem."},{"key":"303677_CR17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/10611869409015910","volume":"2","author":"J. M\u00f6nkk\u00f6nen","year":"1994","unstructured":"J. M\u00f6nkk\u00f6nen, M. Taskinen, S. O. K. Auriola, and A. Urtti. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. J. Drug Target\n2:299-308 (1994).","journal-title":"J. Drug Target"},{"key":"303677_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-1759(93)90144-V","volume":"159","author":"F. E. Nargi","year":"1993","unstructured":"F. E. Nargi and T. J. Yang. Optimization of L-M cell bioassay for quantitating tumor necrosis factor in serum and plasma. J. Immunol. Methods\n159:81-91 (1993).","journal-title":"J. Immunol. Methods"},{"key":"303677_CR19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0192-0561(95)00030-6","volume":"17","author":"N. Pennanen","year":"1995","unstructured":"N. Pennanen, S. Lapinjoki, A. Palander, A. Urtti, and J. Monkkonen. Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion. Int. J. Immunopharmacol.\n17:475-480 (1995).","journal-title":"Int. J. Immunopharmacol."},{"key":"303677_CR20","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1023\/A:1016281608773","volume":"12","author":"N. Pennanen","year":"1995","unstructured":"N. Pennanen, S. Lapinjoki, A. Urtti, and J. Monkkonen. Effect of liposomal and free bisphosphonates on the IL-1\u03b2, IL-6 and TNF\u03b1 secretion from RAW 264 cells in vitro. Pharm. Res.\n12:916-922 (1995).","journal-title":"Pharm. Res."},{"key":"303677_CR21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1018956516640","volume":"9","author":"G. Golomb","year":"1992","unstructured":"G. Golomb, A. Schlossman, H. Saadeh, M. Levi, J. M. Van Gelder, and E. Breuer. Bisacylphosphonates inhibit hydroxyapatite formation and dissolution in vitro and dystrophic calcification in vivo. Pharm. Res.\n9:143-148 (1992).","journal-title":"Pharm. Res."},{"key":"303677_CR22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1359\/jbmr.1998.13.2.253","volume":"13","author":"R. J. Brown","year":"1998","unstructured":"R. J. Brown, E. van Beek, D. J. Watts, C. W. Lowik, and S. E. Papapoulos. Differential effects of aminosubstituted analogs of hydroxy bisphosphonates on the growth of Dictyostelium discoideum. J. Bone. Miner. Res.\n13:253-258 (1998).","journal-title":"J. Bone. Miner. Res."},{"key":"303677_CR23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/8756-3282(95)00081-N","volume":"16","author":"J. M. Van Gelder","year":"1995","unstructured":"J. M. Van Gelder, E. Breuer, A. Ornoy, A. Schlossman, N. Patlas, and G. Golomb. Anticalcification and antiresorption effects of bisacylphosphonates. Bone\n16:511-520 (1995).","journal-title":"Bone"},{"key":"303677_CR24","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.165.3899.1264","volume":"165","author":"M. D. Francis","year":"1969","unstructured":"M. D. Francis and R. G. G. Russell. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science\n165:1264-1266 (1969).","journal-title":"Science"},{"key":"303677_CR25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jbmr.5650090521","volume":"9","author":"J. R. Green","year":"1994","unstructured":"J. R. Green, K. Muller, and K. A. Jaeggi. Preclinical pharmacology of CGP 42\u2032446, a new, potent, heterocyclic bisphosphonate compound. J. Bone Miner. Res.\n9:745-751 (1994).","journal-title":"J. Bone Miner. Res."},{"key":"303677_CR26","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/jbmr.5650090811","volume":"9","author":"C. D. Egger","year":"1994","unstructured":"C. D. Egger, R. C. M\u00fchlbauer, R. Felix, P. D. Delmas, S. Marks, and H. Fleisch. Evaluation of urinary pyridinium crosslinks excretion as a marker of bone resorption in the rat. J. Bone Min. Res.\n9:1211-1219 (1994).","journal-title":"J. Bone Min. Res."},{"key":"303677_CR27","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jbmr.5650100617","volume":"10","author":"D. H. Schweitzer","year":"1995","unstructured":"D. H. Schweitzer, M. Oostendorp-van de Ruit, G. van der Pluijm, C. W. G. M. Lowik, and S. E. Papapoulos. Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylam-inohydroxypropylidene bisphosphonate. J. Bone. Miner. Res.\n10:956-962 (1995).","journal-title":"J. Bone. Miner. Res."},{"key":"303677_CR28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0378-5173(95)00056-O","volume":"123","author":"P. L. Nicklin","year":"1995","unstructured":"P. L. Nicklin, W. J. Irwin, I. F. Hassan, and M. Mackay. Development of a minimum calcium Caco-2 monolayer model: calcium and magnesium ions retard the transport of pamidronate. Int. J. Pharm.\n123:187-197 (1995).","journal-title":"Int. J. Pharm."},{"key":"303677_CR29","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1023\/A:1018981832261","volume":"10","author":"S. C. Sutton","year":"1993","unstructured":"S. C. Sutton, K. Engle, and J. A. Fix. Intranasal delivery of the bisphosphonate alendronate in the rat and dog. Pharm. Res.\n10:924-926 (1993).","journal-title":"Pharm. Res."},{"key":"303677_CR30","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/0006-2952(93)90328-T","volume":"46","author":"X. Boulenc","year":"1993","unstructured":"X. Boulenc, E. Marti, H. Joyeux, Y. Roques, and G. Fabre. Importance of the paracellular pathway for the transport of a new bisphosphonate using the human Caco-2 monolayers model. Biochem. Pharmacol.\n46:1591-1600 (1993).","journal-title":"Biochem. Pharmacol."},{"key":"303677_CR31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.2042-7158.1989.tb06468.x","volume":"41","author":"E. J. van Hoogdalem","year":"1989","unstructured":"E. J. van Hoogdalem, A. T. Wackwitz, A. G. de Boer, and D. D. Breimer. 3-Amino-1-hydroxypropylidene-1, 1-diphosphonate (APD): a novel enhancer of rectal cefoxitin absorption in rats. Pharm. Pharmacol.\n41:339-341 (1989).","journal-title":"Pharm. Pharmacol."},{"key":"303677_CR32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF01622190","volume":"4","author":"E. G. Lufkin","year":"1994","unstructured":"E. G. Lufkin, R. Argueta, M. D. Whitaker, A. L. Cameron, V. H. Wong, K. S. Egan, W. M. O'Fallon, and B. L. Riggs. Pamidronate: an unrecognized problem in gastrointestinal tolerability. Osteoporosis Int.\n4:320-322 (1994).","journal-title":"Osteoporosis Int."},{"key":"303677_CR33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1572-0241.1998.219_a.x","volume":"93","author":"F. Lanza","year":"1998","unstructured":"F. Lanza, M. F. Rack, T. J. Simon, A. Lombardi, R. Reyes, and S. Suryawanshi. Effects of alendronate on gastric and duodenal mucosa. Am. J. Gastroenterol.\n93:753-757 (1998).","journal-title":"Am. J. Gastroenterol."},{"key":"303677_CR34","first-page":"294","volume":"65","author":"J. M\u00f6nkk\u00f6nen","year":"1989","unstructured":"J. M\u00f6nkk\u00f6nen, H. M. Koponen, and P. Yalitalo. Comparison of the distribution of three bisphosphonates in mice. Pharmacol. Toxico.\n65:294-298 (1989).","journal-title":"Pharmacol. Toxico."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018951025493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018951025493\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018951025493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:37:12Z","timestamp":1754033832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018951025493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["303677"],"URL":"https:\/\/doi.org\/10.1023\/a:1018951025493","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}